IPS partners with Dr. Reddy’s for a pharmaceutical project

Industrial Promotion Services (IPS) collaborated with Dr. Reddy’s Laboratories, a research-based global pharmaceutical company with a presence in more than 66 countries globally. Dr Reddy’s is a vertically integrated company with a product portfolio of more than 250 products focussed on therapeutic areas of Cardiology, Diabetes, CNS and Oncology.

Dr. Reddy’s will serve as a technology and strategic partner for EAH Care Ltd., an IPS group pharmaceutical manufacturing facility in Kenya that will produce products for addressing Non-Communicable Diseases (NCDs) and Oncology.

The EAH Care and IPS affiliates in the region will commercialise these products in the East African Community (EAC) countries and intend to gradually scale their operations to other countries in the region. This strategic collaboration aims to provide access to affordable healthcare products to patients in the last mile in the region while maintaining global quality standards.

In line with IPS’s commitment to achieving Net Zero, the EAH Care new facility in Kenya has been designed and is being constructed to meet the IFC EDGE (Excellence in Design for Greater Efficiencies) Advanced Standards as well as certification requirements. The facility will comply with the standards set by the European Union (EU) and the World Health Organization (WHO) prequalification programme.

This partnership represents a significant step towards supporting the Universal Health Coverage (UHC) goal, aligning with SDG3 (Good Health and Well-being).

By Metrine Papa

Regional Communications Officer, East Africa